Authors:
Hall, PD
Virella, G
Willoughby, T
Atchley, DH
Kreitman, RJ
Frankel, AE
Citation: Pd. Hall et al., Antibody response to DT-GM, a novel fusion toxin consisting of a truncateddiphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia, CLIN IMMUNO, 100(2), 2001, pp. 191-197
Authors:
Virella, G
Koskinen, S
Krings, G
Onorato, JM
Thorpe, SR
Lopes-Virella, M
Citation: G. Virella et al., Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies, CLIN IMMUNO, 95(2), 2000, pp. 135-144
Authors:
Huang, Y
Fleming, AJ
Wu, S
Virella, G
Lopes-Virella, MF
Citation: Y. Huang et al., Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase, ART THROM V, 20(12), 2000, pp. 2533-2538
Authors:
Lopes-Virella, MF
Koskinen, S
Mironova, M
Horne, D
Klein, R
Chassereau, C
Enockson, C
Virella, G
Citation: Mf. Lopes-virella et al., The preparation of copper-oxidized LDL for the measurement of oxidized LDLantibodies by EIA, ATHEROSCLER, 152(1), 2000, pp. 107-115
Authors:
Lopes-Virella, MF
Virella, G
Orchard, TJ
Koskinen, S
Evans, RW
Becker, DJ
Forrest, KYZ
Citation: Mf. Lopes-virella et al., Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus, CLIN IMMUNO, 90(2), 1999, pp. 165-172
Authors:
Orchard, TJ
Virella, G
Forrest, KYZ
Evans, RW
Becker, DJ
Lopes-Virella, MF
Citation: Tj. Orchard et al., Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes - A nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications study, DIABETES, 48(7), 1999, pp. 1454-1458